The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $4.37 in the prior trading day, Cardiff Oncology Inc (NASDAQ: CRDF) closed at $4.35, down -0.46%. In other words, the price has decreased by -$0.46 from its previous closing price. On the day, 0.61 million shares were traded. CRDF stock price reached its highest trading level at $4.5695 during the session, while it also had its lowest trading level at $4.26.
Ratios:
Our goal is to gain a better understanding of CRDF by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.41 and its Current Ratio is at 7.41. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
On December 08, 2021, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $19.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 19 ’23 when PACE GARY W bought 30,000 shares for $1.37 per share. The transaction valued at 41,100 led to the insider holds 697,761 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRDF now has a Market Capitalization of 194345808 and an Enterprise Value of 121671688. For the stock, the TTM Price-to-Sale (P/S) ratio is 396.65 while its Price-to-Book (P/B) ratio in mrq is 2.79. Its current Enterprise Value per Revenue stands at 249.327 whereas that against EBITDA is -2.703.
Stock Price History:
Over the past 52 weeks, CRDF has reached a high of $6.42, while it has fallen to a 52-week low of $0.94. The 50-Day Moving Average of the stock is 10.01%, while the 200-Day Moving Average is calculated to be 107.85%.
Shares Statistics:
The stock has traded on average 1.81M shares per day over the past 3-months and 898370 shares per day over the last 10 days, according to various share statistics. A total of 44.68M shares are outstanding, with a floating share count of 41.07M. Insiders hold about 8.07% of the company’s shares, while institutions hold 12.11% stake in the company. Shares short for CRDF as of 1711584000 were 3410807 with a Short Ratio of 1.88, compared to 1709164800 on 1154889. Therefore, it implies a Short% of Shares Outstanding of 3410807 and a Short% of Float of 7.8600004000000006.
Earnings Estimates
A comprehensive evaluation of Cardiff Oncology Inc (CRDF) is underway, with the input of Cardiff Oncology, Inc. analysts contributing to its current rating.The consensus estimate for the next quarter is $16.92, with high estimates of $24.41 and low estimates of $7.21.
